Translations:Lipid-lowering agent/1/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
Importing a new version from external source |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Drug List/ja}} | |||
{{PathNav|Medication|frame=1}} | {{PathNav|Medication|frame=1}} | ||
{| class="wikitable sortable" style="width:100%" | |||
|+脂質降下薬（その他） | |||
|- | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!創薬/開発 | |||
!備考 | |||
|- | |||
|[[Omega-3 acid ethyl esters/ja]] | |||
|[https://www.takedamed.com/medicine/detail?medicine_id=601 ロトリガ](武田薬品) ([https://pins.japic.or.jp/pdf/newPINS/00060775.pdf PI]) ([https://www.takedamed.com/medicine/detail?medicine_id=601&setpopflage=true IF]) | |||
|販売 | |||
|[[Takeda Pharmaceutical Company]] | |||
| | |||
|- | |||
|[[Ethyl eicosapentaenoic acid/ja]] | |||
|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF]) | |||
|販売 | |||
|[[Mochida Pharmaceutical]] | |||
| | |||
|- | |||
|} | |||
'''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. | '''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. | ||
Latest revision as of 10:25, 16 April 2024
薬一覧 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| 一般名 | 先発名 | 日本 | 創薬/開発 | 備考 |
|---|---|---|---|---|
| オメガ-3脂肪酸エチルエステル | ロトリガ(武田薬品) (PI) (IF) | 販売 | Takeda Pharmaceutical Company | |
| イコサペント酸エチル | エパデール(持田製薬) (PI) (IF) | 販売 | Mochida Pharmaceutical |
Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'.